The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis-Reference-Cited by-同舟云学术

The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis

Published:2018-07-05 Issue:10 Volume:73 Page:2667-2674
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Whitfield Michael G¹,Warren Robin M¹,Mathys Vanessa²,Scott Lesley³⁴,De Vos Elise⁵,Stevens Wendy³⁴,Streicher Elizabeth M¹,Groenen Guido⁶,Sirgel Frederick A¹,Van Rie Annelies⁵

Affiliation:

1. South Africa Medical Research Council (SAMRC) Centre for Tuberculosis Research DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa

2. Bacterial Diseases Service, Operational Direction Communicable and Infectious Diseases, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium

3. National Health Laboratory Services, South Africa

4. Department of Molecular Medicine and Haematology, University of Witwatersrand, School of Pathology Faculty of Health Science, Johannesburg, South Africa

5. Global Health Institute, Epidemiology and Social Medicine Faculty of Medicine, University of Antwerp, Antwerp, Belgium

6. Belgian Lung and Tuberculosis Association, Brussels, Belgium

Funder

National Institutes of Health

Flemish Research Foundation

The Belgian National Reference Center

Belgian Ministry of Social Affairs

the Health Insurance System

South African Medical Research Council

Claude Leon Foundation

Publisher

Oxford University Press (OUP)